IN8bio, Inc. (INAB)

IN8bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	17.96	27.09	11.12	21.28	18.18	37.02
Cash & Short-Term Investments	17.96	27.09	11.12	21.28	18.18	37.02
Cash Growth	35.76%	143.63%	-47.75%	17.05%	-50.89%	105.74%
Prepaid Expenses	0.18	0.53	0.71	3.07	3.82	1.91
Other Current Assets	0.36	0.26	0.75	0.27	0.23	0.05
Total Current Assets	18.5	27.88	12.58	24.63	22.23	38.98
Property, Plant & Equipment	2.97	4.04	7.83	8.57	10.3	2.83
Other Long-Term Assets	0.28	0.37	0.54	0.51	0.51	0.41
Total Assets	21.75	32.28	20.94	33.71	33.04	42.22

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	0.44	0.31	0.39	0.92	2.09	0.4
Accrued Expenses	0.76	1.63	1.05	2.96	2.34	1.24
Current Portion of Leases	1.05	1.22	1.65	1.51	1.39	0.63
Total Current Liabilities	2.25	3.16	3.08	5.39	5.82	2.26
Long-Term Leases	1.13	1.56	3.38	3.38	4.49	1.78
Total Liabilities	3.38	4.72	6.47	8.77	10.31	4.04

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.01	0.01	0.01	0	0	0
Additional Paid-In Capital	169.32	168.64	136.13	116.15	83.94	70.87
Retained Earnings	-150.97	-141.1	-121.66	-91.22	-61.21	-32.69
Total Common Equity	18.36	27.56	14.48	24.94	22.73	38.18
Shareholders' Equity	18.36	27.56	14.48	24.94	22.73	38.18
Total Liabilities & Equity	21.75	32.28	20.94	33.71	33.04	42.22

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	2.18	2.78	5.03	4.89	5.87	2.41
Net Cash (Debt)	15.78	24.31	6.09	16.39	12.31	34.61
Net Cash Growth	56.10%	299.18%	-62.84%	33.16%	-64.44%	94.23%
Net Cash Per Share	1.25	5.56	3.41	16.46	17.61	104.15
Filing Date Shares Outstanding	9.86	9.85	2.71	1.44	0.83	0.63
Total Common Shares Outstanding	9.85	9.77	2.42	1.44	0.82	0.63
Working Capital	16.24	24.72	9.5	19.23	16.41	36.72
Book Value Per Share	1.86	2.82	5.99	17.28	27.78	60.99
Tangible Book Value	18.36	27.56	14.48	24.94	22.73	38.18
Tangible Book Value Per Share	1.86	2.82	5.99	17.28	27.78	60.99
Machinery	1.03	0.79	0.85	0.75	0.69	0.44
Construction In Progress	-	-	-	0.18	0.03	0.4
Leasehold Improvements	3.92	3.92	3.92	3.92	3.9	-

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 6, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 2, 2026

Data Sources Report a data error